Vardenafil hydrochloride hydrate

This classification denotes a cgmp phosphodiesterase inhibitor with the molecular formula C23H32N6O4S.ClH.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5M8S2CU0TS, chemically known as imidazo(5,1-f)(1,2,4)triazin-4(1h)-one, 2-(2-ethoxy-5-((4-ethyl-1-piperazinyl)sulfonyl)phenyl)-5-methyl-7-propyl-, hydrochloride, hydrate (1:1:3), but more generally known as vardenafil hydrochloride hydrate, which bears US NIH Compound Identifier 6918463. European Medicines Agency schedules vardenafil hydrochloride hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20047. Most nations, for tariff purposes, schedule vardenafil hydrochloride hydrate under HS 29350090. SMILES: CCCC1NC(C2N1[NH]C(NC2=O)C3CC(CCC3OCC)S(=O)(=O)N4CCN(CC4)CC)C.O.O.O.CL.